or Try an Advanced Search...

    ETF Components for IBB - iShares Nasdaq Biotechnology Index Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    GILD A 0.12 8.92
    REGN D -0.41 8.77
    AMGN D -0.59 7.92
    VRTX D 1.01 7.90
    IQV F -2.36 4.17
    ALNY B 0.37 3.09
    MTD B -1.47 2.83
    BIIB F -1.57 2.77
    ARGX A 0.96 2.45
    MRNA F -4.34 2.44

    Represented by ETF Holdings

    Keywords: S&P 500 Nasdaq 100 Biotechnology Biopharmaceutical Inflammation Medicine Life Sciences Autoimmune Disease Bone Breakthrough Therapy Cancer Cardiovascular Disease Cholesterol Clinical Development Coronavirus Cystic Fibrosis Hemophilia Immunology Infection Influenza
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research

    Recent News for iShares Nasdaq Biotechnology Index Fund & its Holdings

    Date Stock Title
    Oct 1 GILD $1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
    Oct 1 IBB Here's how AI is set to disrupt healthcare — albeit slowly
    Oct 1 MRNA The Covid Era Tech Promises To Reinvent Cancer Treatment
    Oct 1 AMGN Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi
    Oct 1 MRNA ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
    Oct 1 MRNA Is Moderna, Inc. (MRNA) the Worst Performing Stock to Buy on the Dip?
    Oct 1 MRNA MRNA Begins Dosing in Pivotal Study on Norovirus Vaccine
    Oct 1 ALNY Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
    Oct 1 MRNA Company News for Oct 1, 2024
    Oct 1 AMGN LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
    Oct 1 ALNY Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
    Oct 1 MRNA IGM lays off staff in autoimmune pivot; Metsera ramps up obesity drug supply
    Oct 1 GILD Gilead Sciences: My Worst Stock Move In 2024, And What I Learned From It
    Oct 1 VRTX 5 FDA decisions to watch in the fourth quarter
    Oct 1 MRNA Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
    Oct 1 MRNA Moderna, Cenra Healthcare enter JV to promote mRNA respiratory vaccine in Taiwan
    Oct 1 MRNA Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
    Sep 30 VRTX Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
    Sep 30 AMGN Amgen must face lawsuit claiming it hid $10.7 billion tax bill
    Sep 30 REGN Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
    The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
    Exchange Traded Fund ETF Stock Market Index Biotechnology Pharmaceutical Nasdaq Composite Index Industry Classification Nasdaq Biotechnology Index
    Back to the Main IBB Page...